Biomedical Evidence is Essential
To successfully perform critical functions such as pharmacovigilance, generating high-quality systematic reviews in support of evidence-based medicine and drug and medical device efficacy studies, pharmaceutical and life sciences organizations require a wide array of biomedical evidence.
Embase increases the discovery of biomedical evidence to support critical life sciences functions, delivering relevant, up-to-date biomedical information to the global biomedical research community.
Real Stories. Real Science. Real Time.
Visit the Hive to explore how biotech and pharma start-ups are using Elsevier R&D solutions to solve for early-stage drug discovery and development. Watch videos, read real-world case studies and learn how early innovation starts with rapid results and early access to research that is crucial to reducing the likelihood of costly late stage failures and mitigating risk.
Relevant and Accessible Biomedical Information
Over 30 million abstracts and indices from published, peer-reviewed biomedical literature, in-press publications and conferences are available on Embase. Full-text indexing of drug, disease and medical device data, supported by the Embase thesaurus Emtree, facilitates precise searching.
Embase is Now Available for Individuals!
Give Embase a try with 7-day access or subscribe for 30 days to complete a single systematic review project. Annual subscription access is also available to support multiple users and organizations.
Embase Fact Sheet
Embase is ideally suited for pharmacovigilance, systematic reviews and biomedical research. Delve into its unique features and functionality.